The HitLab team from National Cheng Kung University participated in the "Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conference" held on May 26-27, 2025. The event was jointly organized by the Translational Biomedical Research Center of Academia Sinica, the Taiwan Antibody Society, and the Professor Lin Rong-Yao Academic Education Foundation of Taipei City.

The symposium attracted numerous professionals from industry, government, academia, and research sectors, engaging in in-depth discussions on antibody screening, disease diagnosis, and precision medicine. Over the years, this symposium has drawn more than 400 experts, scholars, and industry representatives annually, fostering lively exchanges and receiving high praise. This year continues the tradition of promoting profound dialogue between academia and industry, with a special focus on nurturing young talents by providing valuable opportunities to interact and learn from top experts and scholars in the biotech and medical fields.

Since its inception, the symposium has become an important platform for sharing cutting-edge biomedical science knowledge and exploring innovative collaboration models. Its influence in advancing the biotech and medical sectors is significant and well-recognized.

At the event, the HitLab team set up a booth, actively introducing the high-throughput Protein Microarray technology services to professionals from academia, clinical medicine, and the biotech industry. They also presented the latest chip service offerings and alliance membership programs, sincerely inviting interested researchers and industry partners to explore further collaboration.

2025抗體藥物暨第20屆前瞻生醫新知研討會
2025 Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conference Date
📌Date：May 26 (Mon) – May 27 (Tue), 2025｜2025年5月26日（星期一）至5月27日（星期二）
📍Cite：International Conference Hall C201, National Biotechnology Research Park｜國家生技研究園區 國際會議廳C201

The HitLab protein microarray technology platform enables you to achieve—
✅ Precise analysis of antibody specificity
✅ Comprehensive mapping of protein-protein interactions using proteome microarrays
✅ Support for drug target analysis and disease biomarker screening
✅ Antibody microarray chips for AKT, MAPK signaling pathway, and biomarker analysis
♥ Customized assays tailored to your experimental design

Our team offers the following services with limited-time special discounts. Please feel free to contact us via email or phone for inquiries!

📌 E. coli protein microarray chip (approximately 4,300 proteins)
📌 Yeast protein microarray chip (approximately 5,800 proteins)
📌 Human HuProt™ protein microarray chip (in collaboration with CDI Labs, USA, covering over 21,000 full-length human proteins)

Join the alliance membership to enjoy an additional 20% off, along with:
📌 Exclusive technical consultation
📌 Rapid experimental design support
📌 Priority access to technical support and collaborative resources